DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Optiemus Infracom Limited — Shareholders meeting

NSE 1 hr ago·28 Sept 2026, 10:44 am

Optiemus Infracom

Optiemus Infracom Limited has announced that it will hold a meeting of its shareholders. The company has informed the stock exchange about this upcoming event, which is a standard procedural step for any listed firm. This meeting is likely to be convened to discuss specific agenda items, such as approving financial statements, appointing directors, or considering other corporate actions that require shareholder approval.

For investors, this development is largely procedural and does not immediately signal a major strategic shift or a change in the company's operational outlook. It serves as a reminder for shareholders to stay updated on the company's official communications. Investors should watch for the agenda details and the outcome of the meeting to understand if any significant corporate decisions are being made that could impact the stock's performance in the future.